ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program

... Phase 1 clinical trial for NTCD (non-toxigenic clostridium difficile ), a novel treatment approach for preventing recurrent clostridium difficile infections (CDI). NTCD contains the ... patients taking antibiotics." About clostridium difficile One of the most serious problems ...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

... infections of the gastrointestinal (GI) tract, clostridium difficile infection (CDI) and enterocolitis ... Vancocin is the only approved product to treat clostridium difficile -associated pseudomembranous colitis, ... and devastating hospital-acquired infections. clostridium difficile infection (CDI) can be severe, and ...

Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection

... 45-minute detection of the bacterium that causes clostridium difficile infection (CDI). The Xpert C. ... cleared for the direct detection of toxigenic clostridium difficile from stool specimens. The test targets ... gene is the critical component of all toxigenic clostridium difficile strains -- including the epidemic ...

ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products

... Vancocin is the only approved product to treat clostridium difficile -associated pseudomembranous colitis, ... and devastating hospital-acquired infections. clostridium difficile infection (CDI) can be severe, and ... to bioequivalence for Vancocin." About clostridium difficile One of the most serious problems ...

BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

... detection of the Toxin B gene found in toxigenic clostridium difficile, the bacterial pathogen responsible for clostridium difficile infection (CDI). It is the first CDI ... that allows same-day identification of toxigenic clostridium difficile," said Thomas Davis, M.D., Ph.D., ...

Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients

... N.J., Dec. 17 /PRNewswire/ -- Management of clostridium difficile infection (CDI) in geriatric and ... series entitled Current Concepts in clostridium difficile Infection . The third issue of this ... released and is entitled Current Concepts in clostridium difficile Infection: A Focus on Geriatric and ...

ViroPharma Provides Update on Vancocin(R)

... studies with clinical endpoints in patients with clostridium difficile. Importantly, FDA has also ... the process considers the potential severity of clostridium difficile infections and its effect on a ... pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by ...

Intestinal Infection Afflicts 13 of 1,000 Hospital Patients, Infection Rates 6.5 - 20 Times Greater Than Previous Estimates, New Study Says

... (APIC). "The National Prevalence Study of clostridium difficile in U.S. Healthcare Facilities" ... APIC has published a "Guide to the Elimination of clostridium difficile in Healthcare Settings." ... The APIC National Prevalence Study of clostridium difficile in U.S. Healthcare Facilities will be ...

Abortion drug's off-label use may have led to deaths

... can allow a normally non-threatening bacterium, clostridium sordellii , to gain the upper hand and cause ... after medication abortions are rare, and clostridium infections after abortion are exceedingly rare," ... been eight reported deaths after infections of clostridium bacteria. The drug was given vaginally in all but ...

Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

... Poster Sessions ~ ~ Replidyne Debuts New clostridium difficile Program ~ LOUISVILLE, Colo., Sept. 17 ... newly disclosed lead product candidate to treat clostridium difficile (C. difficile) related diseases, a ... of Methionyl tRNA Synthestase from clostridium difficile: Identification and Synthesis of ...

Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test

... QUIK CHEK COMPLETE (TM) rapid test as an in vitro diagnostic aid for clostridium difficile associated disease (CDAD). This follows TECHLAB(R), Inc.'s ... Recently-released results from the "National Prevalence Study of clostridium difficile in US Healthcare Facilities" indicate that the rate of ...

FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia

... Bacteroides thetaiotaomicron, Bacteroides uniformis, Bacteroides vulgatus, clostridium perfringens, and Peptostreptococcus micros. Community-acquired ... below age 18 and lactating women have not been established clostridium difficile -associated diarrhea (CDAD) has been reported with use of nearly ...

Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen

... VOORHEES, N.J., March 23 /PRNewswire/ -- The epidemiology of clostridium difficile infection (CDI) is changing rapidly and has been marked by a ... sponsoring a complimentary continuing education virtual lecture titled clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen. ...

Interview with GI Experts: Discussions in Clostridium difficile

... Podcast VOORHEES, N.J., Feb. 26 /PRNewswire/ -- The epidemiology of clostridium difficile infection (CDI) is changing and has been marked by increasing ... lecture and podcast titled, Interview with GI Experts: Discussions in clostridium difficile. "Robert Michael Educational Institute LLC recognizes that ...

Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management

... for Healthcare Professionals VOORHEES, N.J., Jan. 19 /PRNewswire/ -- clostridium difficile infection (CDI) is increasingly being seen in older adults, ... a complimentary continuing education Medscape virtual lecture entitled, " clostridium difficile Infection in Long-Term Care: Tailored Approaches to ...

APIC Covers Up Extent and Causes of Deadly C. diff

... (APIC) announced the results of a nationwide survey on the incidence of clostridium difficile infections among hospital patients. "Unfortunately, APIC failed ... (RID). "The new data show that approximately 329,196 patients contracted clostridium difficile (C. diff) in healthcare facilities this year." What's puzzling ...

Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market

... time, European hospitals will have access to a reliable, rapid test for clostridium difficile, which simultaneously detects and identifies the commonly ... published incidence rates, there are approximately 58,000 annual cases of clostridium difficile-associated disease (CDAD) in the United Kingdom. A recent health ...

ViroPharma Incorporated Reports Third Quarter 2008 Financial Results

... of the year, the need for this proven safe and effective treatment for clostridium difficile disease remains at an all time high, and we believe that our ... for treatment of antibiotic-associated pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by Staphylococcus aureus, including ...

Advances in C. difficile research

... research into the toxins, virulence, spread and prevention of the superbug clostridium difficile is reported in the June special issue of the Journal of Medical ... us with ammunition in the fight against a sometimes deadly pathogen. clostridium difficile is found in the environment but is most common in hospitals. It ...

The balance shifts

... The risk of contracting a clostridium difficile infection following operations for which a "prophylactic" ... of the human intestine. In this altered environment, a bacterium named clostridium difficile can thrive. An infection with C. difficile can cause severe ...

APIC Conference to Focus on Patient Safety and 'Targeting Zero' Initiatives to Reduce HAIs

... initiatives promoting best practices and elimination strategies for clostridium difficile-associated disease and infections that the Centers for Medicare ... for Medicare and Medicaid Services -- "The Changing Epidemiology of clostridium difficile," L. Clifford McDonald, MD, Medical Epidemiologist, Centers ...

APIC conference to focus on patient safety and 'Targeting Zero' initiatives to reduce HAIs

... initiatives promoting best practices and elimination strategies for clostridium difficile-associated disease and infections that the Centers for Medicare ... for Medicare and Medicaid Services The Changing Epidemiology of clostridium difficile, L. Clifford McDonald, MD, Medical Epidemiologist, Centers for ...

NUCRYST Announces Management Realignment and R&D Portfolio Change

... NUCRYST, and we wish her success in her future endeavors." About clostridium difficile clostridium difficile (also called C. difficile or C. diff) is a bacterium that is ...

UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria

... Global Health, plans to take a unique approach to treating the bacterium clostridium difficile, which is growing increasingly resistant to certain antibiotics that work against bacteria of the colon. clostridium difficile (C. diff) is a bacterium that causes diarrhea and can lead to ...

Prototype, 7-foot-tall sanitizer automates disinfection of hard-to-clean hospital equipment

... who have patent applications pending, say more studies must be done to determine if SUDS is effective for other hospital superbugs, notably, clostridium difficile. ...

ViroPharma Incorporated Reports Second Quarter 2009 Financial Results

... ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 ...

Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation

... much the same way as BOTOX® injections, and may now be considered one of its main competitors. Dysport® is a protein derived from clostridium botulinum, and has been in use in Europe for several years. It’s designed to smooth out frown lines and wrinkles in the face by temporarily ...

Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award

... help protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as infection with clostridium difficile ( C. difficile ). "ConvaTec is proud to receive this recognition for Flexi-Seal((R) )FMS from our important customers in ...

ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009

... ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 ...

Changes Reduced Infections From Medical Abortion

... 98.5 percent of cases. But in 2005, authorities reported the deaths of five North American women from an otherwise rare bacterial infection -- clostridium sordellii -- within a week of taking mifepristone. In 2006, Planned Parenthood substituted buccal misoprostol for vaginal misoprostol along with ...

Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative

... relaxing facial muscles, thereby reducing and smoothing away frown-lines and wrinkles. Dysport, like Botox, is a protein extracted from the bacterium clostridium Botulinum. Dysport has been available in Europe, Asia and South America for over 10 years. Dysport is manufactured by Ipsen Pharmaceuticals (FRA) and ...

CDC Report on Foodborne Illness is Skewed by Single Large Outbreak

... in an Alabama jail or prison in March 2006 which is suspected (but not confirmed, according to a publicly available CDC database) to result from clostridium perfringens in baked chicken. Without this single incident, poultry would account for 614 of 5,653 cases, or 10.9 percent. This would place poultry ...

Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers

... divert fecal matter, protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as clostridium difficile (C. difficile ). The Solutions(R) Algorithms Interactive Resource is available on CD-ROM by calling 1-800-422-8811. ...

ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors

... ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 ...

Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference

... Staphylococcus aureus (MRSA) infection have more than tripled since 2000 and represent $20 billion in excess healthcare costs each year. Similarly, clostridium difficile infections have been increasing in incidence and severity, and have become a substantive and growing burden in hospitalized patients, ...

AGA Institute presents cutting-edge research during DDW

... Room E451B, the AGA Institute will feature its late-breaking clinical abstracts, which include exciting data on: OPT-80 versus vancomycin in clostridium difficile infection: Results of a randomized clinical trial. M. Miller et al. (2:15 p.m.) Phase II Efficacy of Human Monoclonal Antibody Treatment ...

BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays

... pathogens including methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus aureus , vancomycin-resistant enterococcus and toxigenic clostridium difficile. The BD GeneOhm(TM) MRSA assay has been used to test over 4 million patients worldwide for carriage of the potentially lethal MRSA ...

BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal Tetanus

... in India have eliminated MNT, and many more countries are close to eliminating the disease. About MNT Tetanus is caused by the spores of clostridium tetani, a bacterium that lives on dead or decaying matter. MNT represents a very high proportion of the total tetanus disease burden due mainly to ...

ViroPharma to Present at Two May Healthcare Conferences

... ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by clostridium difficile and enterocolitis caused by Staphylococcus aureus , including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 ...

Swine Flu: Infection Control in Hospitals Will Be Critical

... the hospital, according to the Centers for Disease Control and Prevention. Bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) and clostridium difficile race through hospitals, spread by unwashed hands and unclean equipment. How can hospitals that are failing to prevent ordinary infections ...